Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer.
Drain AP, Zahir N, Northey JJ, Zhang H, Huang PJ, Maller O, Lakins JN, Yu X, Leight JL, Alston-Mills BP, Hwang ES, Chen YY, Park CC, Weaver VM.
Drain AP, et al. Among authors: zhang h.
J Exp Med. 2021 May 3;218(5):e20191360. doi: 10.1084/jem.20191360.
J Exp Med. 2021.
PMID: 33822843
Free PMC article.